VCAM1 and Parkinson disease: For patients with PD, higher serum VCAM-1 level was positively correlated with worsening motor symptoms (MDS-UPDRS score) and disease severity (H&Y stage), which supported that VCAM-1 is a potential biomarker (5, 7).